Jiangsu Hanbon Science and Technology Co., Ltd. (SHA:688755)

China · Delayed Price · Currency is CNY

40.92

-0.07 (-0.17%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Medical Products	690.88M	619.01M	481.79M	320.51M	302.28M
Medical Products Growth	11.61%	28.48%	50.32%	6.03%	-
Total	690.88M	619.01M	481.79M	320.51M	302.28M
Total Growth	11.61%	28.48%	50.32%	6.03%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
China	511.85M	530.51M	451.88M	307.20M	274.77M
China Growth	-3.52%	17.40%	47.10%	11.80%	-
Overseas	178.70M	87.80M	29.42M	12.88M	27.16M
Overseas Growth	103.52%	198.47%	128.46%	-52.60%	-
Total	690.55M	618.32M	481.30M	320.07M	301.93M
Total Growth	11.68%	28.47%	50.37%	6.01%	-

Source: S&P Global Market Intelligence.